Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
21406 | 420 | 39.2 | 80% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
100 | 3 | NEUROSCIENCES//METABOTROPIC GLUTAMATE RECEPTOR//HIPPOCAMPUS | 73970 |
2259 | 2 | METABOTROPIC GLUTAMATE RECEPTOR//MGLUR5//MPEP | 4678 |
21406 | 1 | ETHYL PYRUVATE//PYRUVATE//ANTIDIARRHEIC | 420 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ETHYL PYRUVATE | authKW | 1786251 | 19% | 31% | 79 |
2 | PYRUVATE | authKW | 675229 | 24% | 9% | 99 |
3 | ANTIDIARRHEIC | authKW | 232646 | 1% | 80% | 4 |
4 | ROLLING MEADOWS IL | address | 218107 | 1% | 100% | 3 |
5 | CARDIAC STUNNING | authKW | 166173 | 1% | 57% | 4 |
6 | IFR RMN BIOMED CELLULE HOMME | address | 145405 | 0% | 100% | 2 |
7 | NAT SCI RINS PL LIFE SCI | address | 145405 | 0% | 100% | 2 |
8 | CYTOSOLIC PHOSPHORYLATION POTENTIAL | authKW | 96935 | 0% | 67% | 2 |
9 | INTESTINAL MUCOSAL BLOOD FLOW | authKW | 96935 | 0% | 67% | 2 |
10 | DULBECCOS MODIFIED EAGLES MEDIUM | authKW | 89474 | 1% | 31% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Critical Care Medicine | 848 | 9% | 0% | 38 |
2 | Peripheral Vascular Diseases | 345 | 9% | 0% | 38 |
3 | Cardiac & Cardiovascular System | 304 | 12% | 0% | 49 |
4 | Surgery | 274 | 15% | 0% | 65 |
5 | Physiology | 209 | 9% | 0% | 36 |
6 | Neurosciences | 158 | 14% | 0% | 57 |
7 | Nutrition & Dietetics | 117 | 5% | 0% | 21 |
8 | Pharmacology & Pharmacy | 99 | 11% | 0% | 48 |
9 | Hematology | 80 | 5% | 0% | 21 |
10 | Medicine, Research & Experimental | 77 | 6% | 0% | 26 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ROLLING MEADOWS IL | 218107 | 1% | 100% | 3 |
2 | IFR RMN BIOMED CELLULE HOMME | 145405 | 0% | 100% | 2 |
3 | NAT SCI RINS PL LIFE SCI | 145405 | 0% | 100% | 2 |
4 | ANESTHESIA 0648 | 72702 | 0% | 100% | 1 |
5 | ANTI INFLAMMATORY SIGNALING SURG IMMUNOL | 72702 | 0% | 100% | 1 |
6 | ANZHEN UNIV | 72702 | 0% | 100% | 1 |
7 | ARMED POLICE GEN HOSP | 72702 | 0% | 100% | 1 |
8 | BRANCH IMMUNE CELL THER Y | 72702 | 0% | 100% | 1 |
9 | BURNS HOSP 1 | 72702 | 0% | 100% | 1 |
10 | CLIN NUTR UNITGASTROENTEROL | 72702 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SHOCK | 3604 | 3% | 0% | 14 |
2 | JOURNAL OF SURGICAL RESEARCH | 1994 | 4% | 0% | 17 |
3 | FREE RADICAL RESEARCH | 1554 | 2% | 0% | 8 |
4 | AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 1129 | 3% | 0% | 14 |
5 | JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 538 | 2% | 0% | 7 |
6 | NEUROBIOLOGY OF DISEASE | 311 | 1% | 0% | 4 |
7 | CRITICAL CARE MEDICINE | 294 | 2% | 0% | 7 |
8 | MOLECULAR AND CELLULAR BIOCHEMISTRY | 270 | 1% | 0% | 6 |
9 | NUTRITION | 268 | 1% | 0% | 4 |
10 | RESUSCITATION | 249 | 1% | 0% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KAO, KK , FINK, MP , (2010) THE BIOCHEMICAL BASIS FOR THE ANTI-INFLAMMATORY AND CYTOPROTECTIVE ACTIONS OF ETHYL PYRUVATE AND RELATED COMPOUNDS.BIOCHEMICAL PHARMACOLOGY. VOL. 80. ISSUE 2. P. 151-159 | 46 | 55% | 84 |
2 | FINK, MP , (2008) ETHYL PYRUVATE.CURRENT OPINION IN ANESTHESIOLOGY. VOL. 21. ISSUE 2. P. 160-167 | 44 | 67% | 45 |
3 | FINK, MP , (2007) ETHYL PYRUVATE: A NOVEL ANTI-INFLAMMATORY AGENT.JOURNAL OF INTERNAL MEDICINE. VOL. 261. ISSUE 4. P. 349-362 | 40 | 58% | 79 |
4 | MORO, N , SUTTON, RL , (2010) BENEFICIAL EFFECTS OF SODIUM OR ETHYL PYRUVATE AFTER TRAUMATIC BRAIN INJURY IN THE RAT.EXPERIMENTAL NEUROLOGY. VOL. 225. ISSUE 2. P. 391-401 | 35 | 55% | 21 |
5 | BENNETT-GUERRERO, E , SWAMINATHAN, M , GRIGORE, AM , ROACH, GW , ABERLE, LG , JOHNSTON, JM , FINK, MP , (2009) A PHASE II MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF ETHYL PYRUVATE IN HIGH-RISK PATIENTS UNDERGOING CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS.JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA. VOL. 23. ISSUE 3. P. 324-329 | 25 | 76% | 21 |
6 | CRUZ, RJ , HARADA, T , SASATOMI, E , FINK, MP , (2011) EFFECTS OF ETHYL PYRUVATE AND OTHER ALPHA-KETO CARBOXYLIC ACID DERIVATIVES IN A RAT MODEL OF MULTIVISCERAL ISCHEMIA AND REPERFUSION.JOURNAL OF SURGICAL RESEARCH. VOL. 165. ISSUE 1. P. 151-157 | 23 | 77% | 15 |
7 | SU, FH , WANG, Z , CAI, Y , REMMELINK, M , VINCENT, JL , (2007) BENEFICIAL EFFECTS OF ETHYL PYRUVATE IN SEPTIC SHOCK FROM PERITONITIS.ARCHIVES OF SURGERY. VOL. 142. ISSUE 2. P. 166-171 | 24 | 73% | 18 |
8 | MALLET, RT , SUN, J , KNOTT, EM , SHARMA, AB , OLIVENCIA-YURVATI, AH , (2005) METABOLIC CARDIOPROTECTION BY PYRUVATE: RECENT PROGRESS.EXPERIMENTAL BIOLOGY AND MEDICINE. VOL. 230. ISSUE 7. P. 435 -443 | 36 | 46% | 83 |
9 | KRISTO, G , YOSHIMURA, Y , NIU, JL , KEITH, BJ , MENTZER, RM , BUNGER, R , LASLEY, RD , (2004) THE INTERMEDIARY METABOLITE PYRUVATE ATTENUATES STUNNING AND REDUCES INFARCT SIZE IN IN VIVO PORCINE MYOCARDIUM.AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. VOL. 286. ISSUE 2. P. H517-H524 | 29 | 63% | 19 |
10 | FINK, MP , (2007) ETHYL PYRUVATE: A NOVEL TREATMENT FOR SEPSIS.CURRENT DRUG TARGETS. VOL. 8. ISSUE 4. P. 515-518 | 25 | 61% | 23 |
Classes with closest relation at Level 1 |